Federal Register Notice: FDA will hold a public meeting 5/10 to provide a public update and to gather additional stakeholder input on developing a generic drug user fee program. The meeting will be held from 2 p.m. to 3:30 p.m. at FDA’s White Oak Campus, 10903 New Hampshire Ave., Bldg. 1, Conference Rooms 4101, 4103, and 4105, Silver Spring, MD. Contact Mari Long, (301) 796-7574. To view this notice, click here.
